- Home
- RBNE vs BDRX Comparison
RBNE vs BDRX Comparison
Compare RBNE & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.66
N/A
Current Price
$1.30
Company Overview
Basic Information| Metric | RBNE | BDRX |
|---|---|---|
| Founded | 2024 | 2000 |
| Country | Cyprus | United Kingdom |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.6M |
| IPO Year | 2024 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RBNE | BDRX |
|---|---|---|
| Price | $2.66 | $1.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.6K | ★ 263.0K |
| Earning Date | 04-10-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $42.51 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $0.60 |
| 52 Week High | $8.15 | $11.88 |
Technical Indicators
Market Signals| Indicator | RBNE | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 19.77 |
| Support Level | $2.48 | $0.60 |
| Resistance Level | $3.02 | $1.50 |
| Average True Range (ATR) | 0.16 | 0.11 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 34.86 | 7.22 |
Price Performance
Historical Comparison RBNE
BDRX
About RBNE Robin Energy Ltd.
Robin Energy Ltd is engaged in the ownership and operation of vessels providing seaborne transportation of refined petroleum products and liquefied petroleum gas (LPG). The company operates in two reportable segments: the Tanker segment and the LPG carrier segment.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.